[1] LI Z L, WU H, ZHU J Q et al. Novel strategy for optimized nanocatalytic tumor therapy: from an updated view[J]. Small Science, 2200024(2022).

[2] YANG B W, CHEN Y, SHI J L. Nanocatalytic medicine[J]. Advanced Materials(2019).

[3] WU A, ZHU M, ZHU Y. Copper-incorporated calcium silicate nanorods composite hydrogels for tumor therapy and skin wound healing[J]. Journal of Inorganic Materials, 1203(2022).

[4] ZHU L P, DAI Y L, GAO L Z et al. Tumor microenvironment- modulated nanozymes for NIR-II-triggered hyperthermia-enhanced photo-nanocatalytic therapy via disrupting ROS homeostasis[J]. International Journal of Nanomedicine, 16: 4559(2021).

[5] TANG Z M, ZHAO P R, WANG H et al. Biomedicine meets Fenton chemistry[J]. Chemical Reviews, 1981(2021).

[6] BIAN Y L, LIU B, LIANG S et al. Cu-based MOFs decorated dendritic mesoporous silica as tumor microenvironment responsive nanoreactor for enhanced tumor multimodal therapy[J]. Chemical Engineering Journal, 135046(2022).

[7] ZHANG W J, ZHAO X Y, LÜ J W et al. Progresses on hollow periodic mesoporous organosilicas: preparation and application in tumor therapy[J]. Journal of Inorganic Materials, 1192(2022).

[8] LIU Y, WANG Y H, SONG S Y et al. Cancer therapeutic strategies based on metal ions[J]. Chemical Science, 12234(2021).

[9] SUN Q Q, WANG Z, LIU B et al. Recent advances on endogenous/exogenous stimuli-triggered nanoplatforms for enhanced chemodynamic therapy[J]. Coordination Chemistry Reviews, 451: 214267(2022).

[10] WANG Z, LIU B, SUN Q Q et al. Fusiform-like copper(II) based metal-organic framework through relief hypoxia and GSH-depletion co-enhanced starvation and chemodynamic synergetic cancer therapy[J]. ACS Applied Materials & Interfaces, 17254(2020).

[11] SHENOY N, CREAGAN E, WITZIG T et al. Ascorbic acid in cancer treatment: let the phoenix fly.[J]. Cancer Cell, 700(2018).

[12] DOSKEY C M, BURANASUDJA V, WAGNER B A et al. Tumor cells have decreased ability to metabolize H₂O₂: implications for pharmacological ascorbate in cancer therapy[J]. Redox Biology, 10: 274(2016).

[13] YANG B W, SHI J L. Ascorbate tumor chemotherapy by an iron- engineered nanomedicine catalyzed tumor-specific pro-oxidation[J]. Journal of the American Chemical Society, 21775(2020).

[14] AI Y J, SUN H, GAO Z X et al. Dual enzyme mimics based on metal-ligand cross-linking strategy for accelerating ascorbate oxidation and enhancing tumor therapy[J]. Advanced Functional Materials, 2103581(2021).

[15] WU M Q, DING Y M, LI L L. Recent progress in the augmentation of reactive species with nanoplatforms for cancer therapy[J]. Nanoscale, 11: 19658(2019).

[16] FANG C, DENG Z, CAO G et al. Co-ferrocene MOF/glucose oxidase as cascade nanozyme for effective tumor therapy[J]. Advanced Functional Materials, 30: 1910058(2020).

[17] ZHANG C Y, YAN L, WANG X et al. Tumor microenvironment-responsive Cu₂(OH)PO₄ nanocrystals for selective and controllable radiosentization via the X-ray-triggered Fenton-like reaction[J]. Nano Letters, 1749(2019).

[18] DONG S M, DONG Y S, JIA T et al. GSH depleted nanozymes with hyperthermia-enhanced dual enzyme-mimic activities for tumor nanocatalytic therapy[J]. Advanced Materials(2020).

[19] CHEN T, ZENG W W, LIU Y Q et al. Cu-doped polypyrrole with multi-catalytic activities for sono-enhanced nanocatalytic tumor therapy[J]. Small, 2270152(2022).

[20] NIU J X, SUN S, LIU P F et al. Copper-based nanozymes: properties and applications in biomedicine[J]. Journal of Inorganic Materials, 489(2023).

[21] XU W J, WANG Y P, HOU G H et al. Tumor microenvironment responsive hollow nanoplatform for triple amplification of oxidative stress to enhance cuproptosis-based synergistic cancer therapy[J]. Advanced Healthcare Materials(2023).

[22] XU W J, QIAN J M, HOU G H et al. A hollow amorphous bimetal organic framework for synergistic cuproptosis/ferroptosis/apoptosis anticancer therapy via disrupting intracellular redox homeostasis and copper/iron metabolisms[J]. Advanced Functional Materials, 2205013(2022).

[23] SHAO L J, HU T S, FAN X Y et al. Intelligent nanoplatform with multitherapeutic modalities for synergistic cancer therapy[J]. ACS Applied Materials & Interfaces, 13122(2022).

[24] MIAO Y L, QIU Y D, YANG W J et al. Charge reversible and bio-degradable nanocarriers showing dual pH-/reduction-sensitive disinte-gration for rapid site-specific drug delivery[J]. Colloids and Surfaces B: Biointerfaces, 169: 313(2018).

[25] TESTA U, PELOSI E, CASTELLI G. New promising developments for potential therapeutic applications of high-dose ascorbate as an anticancer drug[J]. Hematology/Oncology and Stem Cell Therapy, 179(2021).

[26] LEVINE M, VIOLET P C. Data Triumph at C.[J]. Cancer cell, 467(2017).

[27] WANG Y W, CHEN J J, TIAN Z F et al. Potassium ferrate-loaded porphyrin-based (VI) metal-organic frameworks for combined photodymanic and chemodynamic tumor therapy[J]. Journal of Inorganic Materials, 1305(2021).

[28] WU W C, YU L D, JIANG Q Z et al. Enhanced tumor-specific disulfiram chemotherapy by in situ Cu²⁺ chelation-initiated nontoxicity-to-toxicity transition[J]. Journal of The American Chemical Society, 11531(2019).

[29] CHENG L C, MA H, SHAO M K et al. Synthesis of folate-chitosan nanoparticles loaded with ligustrazine to target folate receptor positive cancer cells[J]. Molecular Medicine Reports, 1101(2017).

[30] HONG J Y, SUN Z H, LI Y J et al. Folate-modified annonaceous acetogenins nanosuspensions and their improved antitumor efficacy[J]. International Journal of Nanomedicine, 5053(2017).

[31] ZHANG L Z, YANG A J, RUAN C P et al. Copper-nitrogen- coordinated carbon dots: transformable phototheranostics from precise PTT/PDT to post-treatment imaging-guided PDT for residual tumor cells[J]. ACS Applied Materials & Interfaces, 325(2023).